Literature DB >> 30104077

Long non-coding RNAs expression levels in diffuse large B-cell lymphoma: An in silico analysis.

Fatemeh Dousti1, Arman Shahrisa2, Hossein Ansari3, Mohammadreza Hajjari4, Yaser Tahmasebi Birgani5, Javad Mohammadiasl6, Maryam Tahmasebi Birgani7.   

Abstract

Long non-coding RNAs (lncRNAs), are lengthy noncoding transcripts with pivotal roles in biological pathways including cell cycle, apoptosis and chromatin remodeling. Aberrant expression of lncRNAs has been strongly connected with tumor progression and metastasis. However, the prognostic significance of lncRNAs in diffuse large-B-cell lymphoma (DLBCL) remains unclear. In this study, the expression levels of 189 approved lncRNAs were considered in DLBCL patients using several different genomic and transcriptome datasets. The analyses showed that the lncRNA GAS5 allocated the maximum score of RNA dysregulation and can be considered as good choice in DLBCLs' researches.
Copyright © 2018 Elsevier GmbH. All rights reserved.

Entities:  

Keywords:  Bioinformatics analysis; Biomarker; Diffuse large-B-cell lymphoma; GAS5; Long noncoding RNA

Mesh:

Substances:

Year:  2018        PMID: 30104077     DOI: 10.1016/j.prp.2018.08.006

Source DB:  PubMed          Journal:  Pathol Res Pract        ISSN: 0344-0338            Impact factor:   3.250


  8 in total

1.  β-Elemene suppresses tumor growth of diffuse large B-cell lymphoma through regulating lncRNA HULC-mediated apoptotic pathway.

Authors:  Tonglin Hu; Yu Gao
Journal:  Biosci Rep       Date:  2020-02-28       Impact factor: 3.840

Review 2.  Non-Coding RNAs in Diffuse Large B-Cell Lymphoma.

Authors:  Yan Shi; Daihong Ding; Rongfeng Qu; Yan Tang; Shuhong Hao
Journal:  Onco Targets Ther       Date:  2020-11-24       Impact factor: 4.147

3.  Circulating long non-coding RNAs HOTAIR, Linc-p21, GAS5 and XIST expression profiles in diffuse large B-cell lymphoma: association with R-CHOP responsiveness.

Authors:  Mahmoud A Senousy; Aya M El-Abd; Raafat R Abdel-Malek; Sherine M Rizk
Journal:  Sci Rep       Date:  2021-01-22       Impact factor: 4.379

Review 4.  Circulating RNA biomarkers in diffuse large B-cell lymphoma: a systematic review.

Authors:  Philippe Decruyenaere; Fritz Offner; Jo Vandesompele
Journal:  Exp Hematol Oncol       Date:  2021-02-16

Review 5.  Long Noncoding RNAs in Diffuse Large B-Cell Lymphoma: Current Advances and Perspectives.

Authors:  Xianbo Huang; Wenbin Qian; Xiujin Ye
Journal:  Onco Targets Ther       Date:  2020-05-18       Impact factor: 4.147

6.  Long Non-Coding RNA Paternally Expressed Imprinted Gene 10 (PEG10) Elevates Diffuse Large B-Cell Lymphoma Progression by Regulating Kinesin Family Member 2A (KIF2A) via Targeting MiR-101-3p.

Authors:  Jin Zhao; Liping Su; Jianjun Jiang
Journal:  Med Sci Monit       Date:  2020-09-25

7.  lncRNA GAS5, as a ceRNA, inhibits the proliferation of diffuse large B‑cell lymphoma cells by regulating the miR‑18a‑5p/RUNX1 axis.

Authors:  Yinsha Miao; Xiaodong Chen; Mengting Qin; Wen Zhou; Yang Wang; Yanhong Ji
Journal:  Int J Oncol       Date:  2021-10-26       Impact factor: 5.650

Review 8.  Competitive Endogenous RNA Network Involving miRNA and lncRNA in Non-Hodgkin Lymphoma: Current Advances and Clinical Perspectives.

Authors:  Mara Fernandes; Herlander Marques; Ana Luísa Teixeira; Rui Medeiros
Journal:  Biomedicines       Date:  2021-12-17
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.